Improving outcomes for women diagnosed with mucinous ovarian cancer

改善诊断患有粘液性卵巢癌的女性的预后

• 批准号: nhmrc : 1045783
• 负责人: A/Pr Clare Scott
• 金额: $ 39.89万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2013
• 资助国家: 澳大利亚
• 起止时间: 2013-01-01 至 2016-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/improving-outcomes-women-ovarian-cancer/111788
• 关键词: Improving; outcomes; women; diagnosed; mucinous

Mucinous ovarian cancer (MOC) is different from other ovarian cancers but few studies have characterized the genetic changes specific to this subtype. It is often confused with metastases from other organs and does not respond well to standard ovarian cancer therapies. If MOC is more similar to mucinous cancers from other organs than other ovarian cancers, it may be better treated with chemotherapeutics that show success with other mucinous tumours.

粘液性卵巢癌（MOC）与其他卵巢癌不同，但很少有研究描述这种亚型特有的遗传变化。它经常与其他器官的转移相混淆，并且对标准卵巢癌治疗反应不佳。如果MOC与其他器官的粘液性癌症比其他卵巢癌更相似，那么用其他粘液性肿瘤显示成功的化疗药物治疗可能会更好。